Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan's Pharma Companies Should Consolidate, Says Bayer Yakuhin Chairman

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Japan's 1,270 pharmaceutical companies should consolidate to look more like the pharma industry in the U.S. or Germany, Bayer Yakuhin Chairman Norikazu Eiki said at the IBC Drug and Biologics conference in Tokyo Feb. 22
Advertisement

Related Content

Japan's First CRO CMIC On How ICH Affects Clinical Trials in Japan: An Interview with PharmAsia News (Part 2 of 2)
Battling Negative Image Of Generics In Japan (Part 2 of 2)
Battling Negative Image Of Generics In Japan (Part 2 of 2)
Advertisement
UsernamePublicRestriction

Register

SC074325

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel